As reported, the HFHCC diet recapitulated several characteristic features of non-obese NAFLD, including an increased liver-to-body weight ratio, upregulated hepatic CHO and TG levels, increased plasma AST and ALT levels along with elevated fasting glucose, and reduced insulin sensitivity32 (Fig. 8b–h). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.